Respiratory Research
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
25:152.
2024
-
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
24:229.
2023
-
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.
24:106.
2023
-
COPD profiles and treatable traits using minimal resources: identification, decision tree and stability over time.
23:30.
2022
-
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis.
23:54.
2022
-
Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease.
23:8.
2022
-
Role of matrix metalloprotease-2 and MMP-9 in experimental lung fibrosis in mice.
23:180.
2022
-
Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry.
23:207.
2022
-
HuR drives lung fibroblast differentiation but not metabolic reprogramming in response to TGF-β and hypoxia.
22:323.
2021
-
IL-4Rα blockade reduces influenza-associated morbidity in a murine model of allergic asthma.
22:75.
2021
-
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases.
22:84.
2021
-
Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort study.
22:203.
2021
-
Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease.
22:202.
2021
-
Potentiation of long-acting β2-agonist and glucocorticoid responses in human airway epithelial cells by modulation of intracellular cAMP.
22:266.
2021
-
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
21:322.
2020
-
Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis.
21:3.
2020
-
The natural history of progressive fibrosing interstitial lung diseases.
20:57.
2019
-
Effect of continuous positive airway pressure on long-term cardiovascular outcomes in patients with coronary artery disease and obstructive sleep apnea: a systematic review and meta-analysis.
19:61.
2018
-
Microbial dysbiosis and mortality during mechanical ventilation: a prospective observational study.
19:245.
2018
-
Modulation of human airway smooth muscle biology by human adipocytes.
19:33.
2018
-
Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study.
19:19.
2018
-
Attenuating immune pathology using a microbial-based intervention in a mouse model of cigarette smoke-induced lung inflammation.
18:92.
2017
-
Increased IL-17RA and IL-17RC in End-Stage COPD and the Contribution to Mast Cell Secretion of FGF-2 and VEGF.
18:48.
2017
-
Regulation of human airway smooth muscle cell migration and relevance to asthma.
18:156.
2017
-
Increased IL-17RA and IL-17RC in End-Stage COPD and the Contribution to Mast Cell Secretion of FGF-2 and VEGF.
18.
2017
-
Erratum to: Risk factors for mortality in patients admitted to intensive care units with pneumonia.
17:128.
2016
-
IL-25 and IL-33 induce Type 2 inflammation in basophils from subjects with allergic asthma.
17:5.
2016
-
Induction of pulmonary antibodies against oxidized lipids in mice exposed to cigarette smoke.
17:97.
2016
-
Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.
17:157.
2016
-
Risk factors for mortality in patients admitted to intensive care units with pneumonia.
17:80.
2016
-
Decreased expression of the NF-κB family member RelB in lung fibroblasts from Smokers with and without COPD potentiates cigarette smoke-induced COX-2 expression.
16:54.
2015
-
Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study.
16:97.
2015
-
Fibroblast-epithelial cell interactions drive epithelial-mesenchymal transition differently in cells from normal and COPD patients.
16:72.
2015
-
Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
16:14.
2015
-
Small airway epithelial-C/EBPβ is increased in patients with advanced COPD.
16:133.
2015
-
Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial.
15:88.
2014
-
Impact of inflammation, emphysema, and smoking cessation on V/Q in mouse models of lung obstruction.
15:42.
2014
-
Persistence of pulmonary tertiary lymphoid tissues and anti-nuclear antibodies following cessation of cigarette smoke exposure.
15:49.
2014
-
Upregulation of IL-17A/F from human lung tissue explants with cigarette smoke exposure: implications for COPD.
15:145.
2014
-
Cigarette smoke-induced accumulation of lung dendritic cells is interleukin-1α-dependent in mice.
13:81.
2012
-
Differential expression and function of breast regression protein 39 (BRP-39) in murine models of subacute cigarette smoke exposure and allergic airway inflammation.
12:39.
2011
-
Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps.
12:38.
2011
-
Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects.
12:140.
2011
-
Micro-computed tomography of pulmonary fibrosis in mice induced by adenoviral gene transfer of biologically active transforming growth factor-β1.
11:181.
2010
-
Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One.
11:8.
2010
-
Factors affecting exhaled nitric oxide measurements: the effect of sex.
8:82.
2007
-
Airway smooth muscle as a target of asthma therapy: history and new directions.
7:123.
2006
-
Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort.
7:142.
2006
-
Regional differences in the pattern of airway remodeling following chronic allergen exposure in mice.
7:120.
2006
-
Value of supplemental interventions to enhance the effectiveness of physical exercise during respiratory rehabilitation in COPD patients. A Systematic Review.
5:25.
2004
-
A new direction in the pathogenesis of idiopathic pulmonary fibrosis?.
3:1.
2002
-
Tyrosine kinases required for Pseudomonas aeruginosainvasion.
2:68540.
2001
-
CFTR, P. aeruginosa and apoptosis in respiratory epithelium.
2:68571.
2000
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)